Share Email Print

Proceedings Paper

Holmium laser for treatment of benign prostatic hyperplasia: old wine in a new bottle?
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Urinary tract symptoms related to benign prostatic hyperplasia affect 70% of men older than 70 years. Complications are common problems and a significant cause of morbidity in this population, placing a considerable burden on health services. In the early 1990s laser treatment of benign prostatic hyperplasia became widely used after the introduction of the side-firing neodym: YAG laser. However, because of technical limitations and inferior results compared to classical transurethral resection of the prostate many Urologists became desinterested in this device. With the introduction of the holmium: YAG laser a new laser generation became available for use in Urology. Beside several other applications the holmium: YAG laser can be used for incision, ablation, resection, and more recently enucleation of the prostate. In this paper we reviewed the current literature regarding the holmium: YAG laser resection and enucleation of the prostate compared to transurethral resection of the prostate and open prostatectomy. The holmium: YAG laser technique is an effective and durable surgical alternative to standard transurethral resection of the prostate. Interestingly, enucleation of the prostate with this device seems to be a safe and effective procedure for large prostatic adenomas, it may become an attractive alternative to open prostatectomy.

Paper Details

Date Published: 12 September 2003
PDF: 12 pages
Proc. SPIE 4949, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII, (12 September 2003); doi: 10.1117/12.476494
Show Author Affiliations
Thomas Nelius M.D., Robert H. Lurie Comprehensive Cancer Ctr./Northwestern Univ. (United States)
Werner T. W. de Riese, Texas Tech Univ. Health Sciences Ctr. (United States)

Published in SPIE Proceedings Vol. 4949:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems XIII
Eugene A. Trowers M.D.; Lawrence S. Bass M.D.; Udayan K. Shah M.D.; Reza S. Malek M.D.; David S. Robinson M.D.; Kenton W. Gregory M.D.; Lawrence S. Bass M.D.; Abraham Katzir; Nikiforos Kollias; Hans-Dieter Reidenbach; Brian Jet-Fei Wong M.D.; Timothy A. Woodward M.D.; Werner T.W. de Riese; Keith D. Paulsen, Editor(s)

© SPIE. Terms of Use
Back to Top